DOCSLIB.ORG

Season 2018/19

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Season 2018/19 A portion of every bet, betters WA racing. HHARNESSWA WA SEASON 2018/19 SEASON INFO Your season go-to for Showcasing feature race details, the Regions notices and contacts Meet Hayley Wheeler, the face behind the scenes at Collie Harness Racing Club the BRIDGE BAR Michael Radley’s insights on the idea the location the facilities SEASON 2018/19 Our profits stay in WA and fund a better racing industry. THE JOURNEY AHEAD Gamble responsibly. ruok.org.au SEASON 2018/19 FOLLOW RWWA CONTENTS 04 08 12 FEATURES DEPARTMENTS 04 New Season | New Hope 03 WELCOME Tim Walker reminisces about the 2017/18 season, highlighting some of its stand-out performers and talks with industry experts to 16 COMMUNITY TAB preview the 2018/19 season ahead. Young riders competing in the Riding for the Disabled Association WA (RDAWA) 2018 Community TAB State Games. 08 The Bridge Bar Gloucester Park has seized the opportunity 18 BOTRA brought by the new Matagarup Bridge and Details of the third running of the Mouse have created The Bridge Bar, the perfect Racing Day Fundraiser, Stallion Service meeting place before Optus Stadium events. Auction and Downunder Sulky raffle. 21 2018/19 FEATURE RACES 12 Showcasing the Regions A detailed list of all feature race dates Julio Santarelli talks to Collie Harness Racing for the 2018/19 harness racing season. Club volunteer Hayley Wheeler, who's behind- the-scenes contributions to the club do not go unnoticed. 1 HWA SEASON 2018-19 HWA INDUSTRY NOTICES HARNESS WA EDITION 1 29 48 Stewards Notices Amendments to Rules EDITOR: Hayley McDermott of Racing CONTRIBUTING WRITERS: Julio Santarelli, Tim Walker CONTRIBUTING PHOTOGRAPHERS: Scott Hamilton Media, 34 Jessica Ashcroft 54 Veterinary Notices Licensing, Registration and Ownership ALL ENQUIRIES: Hayley McDermott EMAIL: hayley.mcdermott@ rwwa.com.au PHONE: (08) 9445 5533 ADDRESS: 14 Hasler Road Osborne Park WA 6017 ONLINE: rwwa.com.au FACEBOOK: /racingandwageringwa TWITTER: @OfficialRWWA @RWWA_Harness HARNESS RACING DEPARTMENT RACING MANAGER: Barry Hamilton CHIEF HANDICAPPER: Warren Wishart HEAD OFFICE ADDRESS: 14 Hasler Road Osborne Park WA 6017 EMAIL: [email protected] OFFICE HOURS: 7.30am to 4.00pm Monday to Friday DRIVING MASTER: Trevor Warwick CONTACTS MOBILE: 0434 609 604 TRAINERS' CENTRE PH: (08) 9445 5267* 64 FAX: (08) 9445 3056 62 24HR NOM SERVICE PH: (08) 9445 5268* Australian Controlling Trainers and Drivers * N.B. all incoming and outgoing calls are recorded Authorities STEWARDS DEPARTMENT 63 71 GENERAL MANAGER INTEGRITY Denis Borovica WA Harness Racing Concession and PHONE: (08) 9445 5427 DEPUTY CHIEF STEWARD Rhys Chappell Clubs and Training Young Drivers PHONE: (08) 9445 5177 Centres FAX: (08) 9477 5215 EMAIL: [email protected] ASCOT ADDRESS: 70 Grandstand Road Ascot WA 6104 INVESTIGATOR: Geoff Johnson MOBILE: 0408 843 560 LETTERS TO THE EDITOR RWWA INTEGRITY Please send your letters to the editor to [email protected] RECORDED MESSAGE SERVICE: (08) 9445 5565 EMAIL: [email protected] LICENSING, REGISTRATIONS & STAKES ADDRESS: 14 Hasler Road Racing and Wagering WA acknowledges the Australian Aboriginal and Osborne Park WA 6017 EMAIL: [email protected] Torres Strait Islander peoples as the first inhabitants of the nation and PHONE: (08) 9445 5568 the traditional custodians of the lands where we live, learn and work. FAX: (08) 6314 4792 All advertisements published in Harness WA Magazine are the RACING AND WAGERING WA responsibility of the person, company or advertising agency which HEAD OFFICE ADDRESS: 14 Hasler Road submitted them for publication. The publisher and printer do not Osborne Park WA 6017 accept any responsibility for the text of any advertisement. All persons PHONE: (08) 9445 5333 and advertising agencies submitting advertisements are reminded of FAX: (08) 9244 5914 their necessity to comply with the provisions of the Trade Practices EMAIL: [email protected] Act 1974 and any other relevant legislation (including the Rules of WEB: www.rwwa.com.au Racing) applicable to the subject of matter of such advertisement. The publisher carefully checks all material prior to publication. However, the publisher and its employees do not warrant the accuracy of such material nor its compliance with relevant legislation. Copyright of articles COVER and photographs in Harness WA Magazine remains with individual Shutterstock Image contributors and may not be reproduced without permission. Magazine printed by VANGUARD PRINTING - 26 John St, Northbridge 6003 2 WELCOME On behalf of the team at Racing and Wagering WA, we welcome you to the first edition of the new Harness WA magazine, previously known as Racing Ahead WA - Harness. FROM THE EDITOR I love my job, but never Harness WA has been redesigned to celebrate, inform more so than when and inspire the industry with an annual printed edition at reimagining Harness the beginning of each season, and regular monthly digital Racing Ahead WA. editions published online. There has been much This inaugural edition celebrates the new season through talk about the relevance its feature stories, and is also your go-to reference for the of Racing Ahead since season, including feature race details, racing rules, notices, it became an online- and industry contact information. only publication, but In the coming months you can expect to see more for me it became a interactivity with our digital version of Harness WA. time of opportunity; I hope you enjoy Harness WA and invite you to opportunities that participate in one of our new features - Letters to the are being embraced Editor. Send your feedback, suggestions, or anything else wholeheartedly by the team at RWWA. you wish to address to Our digital and social platforms allow us to speak to a [email protected] and your letter may be broader audience than ever before, report on things we published in our next edition with my reply. might otherwise have missed, and engage in a two-way Until next edition, happy reading. conversation with you. We have heard you, and it is for you that we have curated Hayley McDermott the Season 2018/19 printed edition of Harness WA. PUBLICATIONS EDITOR MESSAGE FROM THE RACING MANAGER Welcome to the new look Harness WA magazine, a once a year up date to complement our new on line racing magazine. Barack Obama said “Change will not come if we wait for some other person, or if we wait for some other time. We are the ones we've been waiting for. We are the change that we seek.” So while it is acknowledged that change to some people can feel uncomfortable. Harness Racing, if it is to succeed into the future also needs to change. Over the next 12 months there will be a number of significant changes in the way we program meetings, schedule races, handicap horses as well as how we, provide information and communicate with the Industry. Many of the changes are borne out of the necessity to make Harness Racing more commercially sustainable, to ensure that this great sport continues to prosper well into the future. We cannot continue to rely on the “topping up” of harness distribution through subsidised funding arrangements and must strive to increase our market share and stand on our own two legs financially ever seen and confident that over time we can begin into the future. to increase the number of people involved in the sport whether they be trainers drivers owners or breeders or Other changes however are about improving what just people who love to go to the track and enjoy the we do so that you, our customers, receive a better harness racing action. service, better information and access to more reliable information. I genuinely believe that Harness racing is entering Barry Hamilton some of the most exciting times that this sport has MANAGER HARNESS RACING 3 HWA SEASON 2018-19 TIM WALKER FRANCO EDWARD 2018 THE GOLDEN SLIPPER KING OF SWING 2018 WA DERBY SOHO TRIBECA 2018 WA PACING CUP MY HARD COPY 2018 FREMANTLE CUP CHICAGO BULL NEW SEASON | NEW HOPE2018 MOUNT EDEN SPRINT The 2018/19 WA Harness season is underway new season brings new The two-year-old season in the hope. "With the month of winter months didn’t disappoint either, with the talented Franco The Harness Racing September comes the Edward reigning supreme in the season of 2017/18 will Golden Slipper. A be long remembered commencement of a in Western Australia for some new season and with With the month of September remarkable performances by comes the commencement of a some of the best Standardbreds that new levels of hope new season and with that new to have graced the sport. and excitement" levels of hope and excitement. Early last season the battle Perhaps it was fitting though between three of WA’s best the season closed with a taste Ultimately, it took a herculean pacers Chicago Bull, Soho Tribeca of what’s to come in the new performance from Lazarus in the and Shandale in Free For All races season, a series of commanding Final to take out the event. set the scene for the summer that performances from Chicago Bull. lay in wait. My Hard Copy and Soho Tribeca The best of those performances enjoyed Group 1 success in the The Inter Dominion series then came in the Listed August Cup Fremantle and WA Pacing Cups had a clear favourite in the form which led trainer Gary Hall Snr to respectively, while King Of Swing of Mark Purdon’s Lazarus, but it declare the horse the one to beat overcame a torrid preparation to was a series that had plenty of in any race he starts in over the win the WA Derby. twists and turns.
Load more

Recommended publications
  • Expression of Recombinant Human Androgen Receptor and Its Use for Screening Methods
    Institut für Physiologie FML Weihenstephan Technische Universität München Expression of recombinant human androgen receptor and its use for screening methods Ellinor Rose Sigrid Bauer Vollständiger Abdruck der von der Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften genehmigten Dissertation. Vorsitzender: Univ.-Prof. Dr. B. Hock Prüfer der Dissertation: Univ.-Prof. Dr. H. H. D. Meyer Univ.-Prof. Dr. H. Sauerwein (Rheinische Friedrich-Wilhelms-Universität Bonn) Die Dissertation wurde am 31.10.2002 bei der Technischen Universität München eingereicht und durch die Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt am 03.12.2002 angenommen. Introduction Content 1. INTRODUCTION ..................................................................................................................................... 5 1.1. ENDOCRINE DISRUPTERS 5 1.2. ANDROGENS AND ANTIANDROGENS 7 1.2.1. DEFINITIONS 7 1.2.2. MODE OF ACTION 8 1.3. STRUCTURES OF ENDOCRINE DISRUPTERS 10 1.4. STRATEGIES FOR MONITORING ANDROGEN ACTIVE SUBSTANCES 13 1.4.1. IN VIVO METHODS 13 1.4.2. IN VITRO METHODS 15 1.5. OBJEKTIVE OF THE STUDIES 18 2. MATERIALS AND METHODS ................................................................................................................. 19 2.1. PREPARATION OF RECEPTORS 19 2.2. ASSAY SYSTEMS 19 2.2.1. IN SOLUTION AR ASSAY 19 2.2.2. IMMUNO-IMMOBILISED RECEPTOR ASSAY (IRA) 20 2.2.3. PR AND SHBG ASSAYS 21 2.2.4. DATA EVALUATION 21 2.3. ANALYTES 22 3. RESULTS AND DISCUSSION ................................................................................................................. 23 3.1. DEVELOPMENT OF NEW ASSAY SYSTEMS 23 3.1.1. BAR ASSAY 23 3.1.2. CLONING OF THE HUMAN AR AND PRODUCTION OF FUNCTIONAL PROTEIN 24 3.1.3. DEVELOPMENT OF A SCREENING ASSAY ON MICROTITRE PLATES (IRA) 25 3.2.
    [Show full text]
  • 5 Part 1300—Definitions
    PART 1300—DEFINITIONS (7) 5-androstenediol (3b,17b-dihydroxy- androst-5-ene) Sec. (8) 1-androstenedione ([5a]-androst-1- 1300.01 Definitions relating to controlled en-3,17-dione) substances. (9) 4-androstenedione (androst-4-en- 1300.02 Definitions relating to listed chemi- 3,17-dione) cals. (10) 5-androstenedione (androst-5-en- 1300.03 Definitions relating to electronic or- 3,17-dione) ders for controlled substances and elec- tronic prescriptions for controlled sub- (11) bolasterone (7a,17a-dimethyl-17b- stances. hydroxyandrost-4-en-3-one) 1300.04 Definitions relating to the dis- (12) boldenone (17b-hydroxyandrost-1,4- pensing of controlled substances by diene-3-one) means of the Internet. (13) boldione (androsta-1,4-diene-3,17- 1300.05 Definitions relating to the disposal dione) of controlled substances. (14) calusterone (7b,17a-dimethyl-17b- AUTHORITY: 21 U.S.C. 802, 821, 822, 829, hydroxyandrost-4-en-3-one) 871(b), 951, 958(f). (15) clostebol (4-chloro-17b- SOURCE: 62 FR 13941, Mar. 24, 1997, unless hydroxyandrost-4-en-3-one) otherwise noted. (16) dehydrochloromethyltestosterone (4-chloro-17b-hydroxy-17a-methyl- § 1300.01 Definitions relating to con- androst-1,4-dien-3-one) trolled substances. (17) desoxymethyltestosterone (17a- (a) Any term not defined in this part methyl-5a-androst-2-en-17b-ol) shall have the definition set forth in (a.k.a. ‘madol‘) section 102 of the Act (21 U.S.C. 802), (18) D1-dihydrotestosterone (a.k.a.‘1- except that certain terms used in part testosterone‘) (17b-hydroxy-5a- 1316 of this chapter are defined at the androst-1-en-3-one) beginning of each subpart of that part.
    [Show full text]
  • (Cyp19a1b-GFP) Zebrafish Embryos
    Screening Estrogenic Activities of Chemicals or Mixtures In Vivo Using Transgenic (cyp19a1b-GFP) Zebrafish Embryos Franc¸ois Brion1, Yann Le Page2, Benjamin Piccini1, Olivier Cardoso1, Sok-Keng Tong3, Bon-chu Chung3, Olivier Kah2* 1 Unite´ d’Ecotoxicologie in vitro et in vivo, Direction des Risques Chroniques, Institut National de l’Environnement Industriel et des Risques (INERIS), Verneuil-en- Halatte, France, 2 Universite´ de Rennes 1, Institut de Recherche Sante´ Environnement & Travail (IRSET), INSERM U1085, BIOSIT, Campus de Beaulieu, Rennes France, 3 Taiwan Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan Abstract The tg(cyp19a1b-GFP) transgenic zebrafish expresses GFP (green fluorescent protein) under the control of the cyp19a1b gene, encoding brain aromatase. This gene has two major characteristics: (i) it is only expressed in radial glial progenitors in the brain of fish and (ii) it is exquisitely sensitive to estrogens. Based on these properties, we demonstrate that natural or synthetic hormones (alone or in binary mixture), including androgens or progestagens, and industrial chemicals induce a concentration-dependent GFP expression in radial glial progenitors. As GFP expression can be quantified by in vivo imaging, this model presents a very powerful tool to screen and characterize compounds potentially acting as estrogen mimics either directly or after metabolization by the zebrafish embryo. This study also shows that radial glial cells that act as stem cells are direct targets for a large panel of endocrine disruptors, calling for more attention regarding the impact of environmental estrogens and/or certain pharmaceuticals on brain development. Altogether these data identify this in vivo bioassay as an interesting alternative to detect estrogen mimics in hazard and risk assessment perspective.
    [Show full text]
  • Us Anti-Doping Agency
    2019U.S. ANTI-DOPING AGENCY WALLET CARDEXAMPLES OF PROHIBITED AND PERMITTED SUBSTANCES AND METHODS Effective Jan. 1 – Dec. 31, 2019 CATEGORIES OF SUBSTANCES PROHIBITED AT ALL TIMES (IN AND OUT-OF-COMPETITION) • Non-Approved Substances: investigational drugs and pharmaceuticals with no approval by a governmental regulatory health authority for human therapeutic use. • Anabolic Agents: androstenediol, androstenedione, bolasterone, boldenone, clenbuterol, danazol, desoxymethyltestosterone (madol), dehydrochlormethyltestosterone (DHCMT), Prasterone (dehydroepiandrosterone, DHEA , Intrarosa) and its prohormones, drostanolone, epitestosterone, methasterone, methyl-1-testosterone, methyltestosterone (Covaryx, EEMT, Est Estrogens-methyltest DS, Methitest), nandrolone, oxandrolone, prostanozol, Selective Androgen Receptor Modulators (enobosarm, (ostarine, MK-2866), andarine, LGD-4033, RAD-140). stanozolol, testosterone and its metabolites or isomers (Androgel), THG, tibolone, trenbolone, zeranol, zilpaterol, and similar substances. • Beta-2 Agonists: All selective and non-selective beta-2 agonists, including all optical isomers, are prohibited. Most inhaled beta-2 agonists are prohibited, including arformoterol (Brovana), fenoterol, higenamine (norcoclaurine, Tinospora crispa), indacaterol (Arcapta), levalbuterol (Xopenex), metaproternol (Alupent), orciprenaline, olodaterol (Striverdi), pirbuterol (Maxair), terbutaline (Brethaire), vilanterol (Breo). The only exceptions are albuterol, formoterol, and salmeterol by a metered-dose inhaler when used
    [Show full text]
  • A10 Anabolic Steroids Hardcore Info
    CONTENTS GENERAL INFORMATION 3 Anabolic steroids – What are they? 4 How do they Work? – Aromatisation 5 More molecules – More problems 6 The side effects of anabolic steroids 7 Women and anabolic steroids 8 Injecting steroids 9 Abscesses – Needle Exchanges 10 Intramuscular injection 11 Injection sites 12 Oral steroids – Cycles – Stacking 13 Diet 14 Where do steroids come from? Spotting a counterfeit 15 Drug Information – Drug dosage STEROIDS 16 Anadrol – Andriol 17 Anavar – Deca-Durabolin 18 Dynabolon – Durabolin – Dianabol 19 Esiclene – Equipoise 20 Primobolan Depot – Proviron – Primobolan orals – Pronobol 21 Sustanon – Stromba, Strombaject – Testosterone Cypionate Testosterone Enanthate 22 Testosterone Propionate – Testosterone Suspension 23 Trenbolone Acetate – Winstrol OTHER DRUGS 24 Aldactone – Arimidex 25 Clenbuterol – Cytomel 26 Ephedrine Hydrochloride – GHB 27 Growth Hormone 28 Insulin 30 Insulin-Like Growth Factor-1 – Human Chorionic Gonadotrophin 31 Tamoxifen – Nubain – Recreational Drugs 32 Steroids and the Law 34 Glossary ANABOLIC STEROIDS People use anabolic steroids for various reasons, some use them to build muscle for their job, others just want to look good and some use them to help them in sport or body building. Whatever the reason, care needs to be taken so that as little harm is done to the body as possible because despite having muscle building effects they also have serious side effects especially when used incorrectly. WHAT ARE THEY? Anabolic steroids are man made versions of the hormone testosterone. Testosterone is the chemical in men responsible for facial hair, deepening of the voice and sex organ development, basically the masculine things Steroids are in a man. used in medicine to treat anaemia, muscle weakness after These masculine effects surgery etc, vascular are called the androgenic disorders and effects of testosterone.
    [Show full text]
  • 2010 Prohibited List
    The World Anti-Doping Code THE 2010 PROHIBITED LIST INTERNATIONAL STANDARD The official text of the Prohibited List shall be maintained by WADA and shall be published in English and French. In the event of any conflict between the English and French versions, the English version shall prevail. This List shall come into effect on 1 January 2010 The Prohibited List 2010 19 September 2009 THE 2010 PROHIBITED LIST WORLD ANTI-DOPING CODE Valid 1 January 2010 All Prohibited Substances shall be considered as “Specified Substances” except Substances in classes S1, S2.1 to S2.5, S.4.4 and S6.a, and Prohibited Methods M1, M2 and M3. SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OF-COMPETITION) PROHIBITED SUBSTANCES S1. ANABOLIC AGENTS Anabolic agents are prohibited. 1. Anabolic Androgenic Steroids (AAS) a. Exogenous* AAS, including: 1-androstendiol (5α-androst-1-ene-3β,17β-diol ); 1-androstendione (5α- androst-1-ene-3,17-dione); bolandiol (19-norandrostenediol); bolasterone; boldenone; boldione (androsta-1,4-diene-3,17-dione); calusterone; clostebol; danazol (17α-ethynyl-17β-hydroxyandrost-4-eno[2,3-d]isoxazole); dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta- 1,4-dien-3-one); desoxymethyltestosterone (17α-methyl-5α-androst-2-en- 17β-ol); drostanolone; ethylestrenol (19-nor-17α-pregn-4-en-17-ol); fluoxymesterone; formebolone; furazabol (17β-hydroxy-17α-methyl-5α- androstano[2,3-c]-furazan); gestrinone; 4-hydroxytestosterone (4,17β- dihydroxyandrost-4-en-3-one); mestanolone; mesterolone; metenolone; methandienone
    [Show full text]
  • 伊域化學藥業（香港）有限公司 Cyclopentyl Substituted Compounds
    ® 伊 域 化 學（香 藥 香 港） 業 港有 有 限 限 公 公 司 司 YICK-VIC CHEMICALS & PHARMACEUTICALS (HK) LTD Rm 1006, 10/F, Hewlett Centre, Tel: (852) 25412772 (4 lines) No. 52-54, Hoi Yuen Road, Fax: (852) 25423444 / 25420530 / 21912858 Kwun Tong, E-mail: [email protected] YICKYICK----VICVICVICVIC 伊域伊域伊域 Kowloon, Hong Kong. Site: http://www.yickvic.com Cyclopentyl Substituted Compounds Product Code CAS Product Name CC-0052BA 39746-00-4 (-)-COREY LACTONE BENZOATE CC-3702AD 1211-29-6 (-)-METHYL JASMONATE SPI-4467C 87269-86-1 (-)-OCTAHYDROCYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID HYDROCHLORIDE SPI-4467A 93779-30-7 (+/-)-OCTAHYDROCYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID HYDROCHLORIDE SPI-2956FG 142217-81-0 (1S,3R,4S)-2-AMINO-9-(4-BENZYLOXY)-3-(BENZYLOXYMETHYL)-2-METHYLIDENECYCLOPENTYL-3H-PURINE-9-ONE SPI-2956FJ 142217-78-5 (2R,3S,5S)-3-(BENZYLOXY)-5-[2-[[(4-METHOXYPHENYL)DIPHENYLMETHYL]AMINO]-6-(PHENYLMETHOXY)-9H-PURIN-9-Y L]-2-(BENZYLOXYMETHYL)CYCLOPENTANOL SPI-1560DH 4167-77-5 1,1-CYCLOPENTANEDICARBOXYLIC ACID DIETHYL ESTER SPI-2808C 5763-44-0 1,2-CYCLOPENTANE DICARBOXIMIDE CC-1957B 1222-05-5 1,3,4,6,7,8-HEXAHYDRO-4,6,6,7,8,8-HEXAMETHYLCYCLOPENTA[G]-2-BENZOPYRAN SPI-1246B 3859-41-4 1,3-CYCLOPENTANEDIONE SPI-1955AA 646-06-0 1,3-DIOXOLANE SPI-3082AA 54078-29-4 1,8-DIAZAFLUOREN-9-ONE UNIE-13864 564-35-2 11-KETOTESTOSTERONE SPI-0098CA 640-87-9 17-ALPHA,21-DIHYDROXYPREGN-4-ENE-3,20-DIONE 21-ACETATE UNIE-13126 302-76-1 17ALPHA-METHYL-17BETA-ESTRADIOL UNIE-14695 3563-27-7 17BETA-DIHYDROQUILIN UNIE-2836 10316-79-7 1-AMINO-1-CYCLOPENTANEMETHANOL SPI-3077CB 61379-64-4 1-AMINO-4-CYCLOPENTYLPIPERAZINE
    [Show full text]
  • Misuse of Drugs (Miscellaneous Amendments) (No. 2) (Jersey) Order 2012 Arrangement
    Misuse of Drugs (Miscellaneous Amendments) (No. 2) (Jersey) Order 2012 Arrangement MISUSE OF DRUGS (MISCELLANEOUS AMENDMENTS) (No. 2) (JERSEY) ORDER 2012 Arrangement Article 1 Schedule 2 to the Misuse of Drugs (Jersey) Law 1978 amended .................... 3 2 Schedule to the Misuse of Drugs (Designation) (Jersey) Order 1989 amended .......................................................................................................... 9 3 Misuse of Drugs (General Provisions) (Jersey) Order 2009 amended .......... 11 4 Citation and commencement ......................................................................... 18 ◊ Page - 1 Misuse of Drugs (Miscellaneous Amendments) (No. 2) (Jersey) Order 2012 Article 1 MISUSE OF DRUGS (MISCELLANEOUS AMENDMENTS) (No. 2) (JERSEY) ORDER 2012 Made Coming into force THE MINISTER FOR HEALTH AND SOCIAL SERVICES, in pursuance of Articles 3, 4, 5, 8, 12, 13 and 27 of the Misuse of Drugs (Jersey) Law 1978, and after consultation with the Advisory Council on the Misuse of Drugs, orders as follows – 1 Schedule 2 to the Misuse of Drugs (Jersey) Law 1978 amended (1) In this Article “Law” means the Misuse of Drugs (Jersey) Law 1978. (2) In Part 1 of Schedule 2 to the Law, in paragraph 1(a), after the entry “Sufentanil” there shall be inserted the following entry – “Tapentadol”. (3) In Part 2 of Schedule 2 to the Law – (a) in paragraph 1(a) after the entry “Methylphenobarbitone” there shall be inserted the entry – “Nabilone”; (b) for the full stop at the end of paragraph 1(i) there shall be substituted a semi-colon; and (c) after paragraph 1(i) there shall be added the following sub- paragraphs – “(j) the following substances – 6-(2-aminopropyl)benzofuran 5-(2-aminopropyl)benzofuran; (k) Any compound (not being pipradrol) structurally derived from piperidine, pyrrolidine, azepane, morpholine or pyridine by substitution at a ring carbon atom with a diphenylmethyl group, whether or not the compound is further modified in any of the following ways, that is to say – ◊ Page - 3 Misuse of Drugs (Miscellaneous Amendments) (No.
    [Show full text]
  • TGA Review of Hgps
    A REVIEW TO UPDATE AUSTRALIA’S POSITION ON THE HUMAN SAFETY OF RESIDUES OF HORMONE GROWTH PROMOTANTS (HGPs) USED IN CATTLE Prepared by Chemical Review and International Harmonisation Section Office of Chemical Safety Therapeutic Goods Administration of the Department of Health and Ageing Canberra July 2003 A draft of this report was tabled at the 25th Meeting of the Advisory Committee on Pesticides and Health (ACPH), held in Canberra on the 1st May 2003. The report was subsequently endorsed out-of-session by the ACPH. Hormone Growth Promotants TABLE OF CONTENTS ABBREVIATIONS ................................................................................................................................................................4 EXECUTIVE SUMMARY ..................................................................................................................................................7 INTRODUCTION..................................................................................................................................................................9 HEALTH CONCERNS ASSOCIATED WITH HGP S................................................................................................................9 DIFFICULTIES ASSOCIAT ED WITH ASSESSING THE SAFETY OF HGPS.........................................................................10 RISK ASSESSMENTS OF HGP S .........................................................................................................................................10 PURPOSE OF THE CURRENT
    [Show full text]
  • Biodegradation of the Steroid Progesterone in Surface Waters
    Biodegradation of the Steroid Progesterone in Surface Waters A Thesis Submitted for the Degree of Doctor of Philosophy By Jasper Oreva Ojoghoro Institute of the Environment, Health and Societies May, 2017 Abstract Many studies measuring the occurrence of pharmaceuticals, understanding their environmental fate and the risk they pose to surface water resources have been published. However, very little is known about the relevant transformation products which result from the wide range of biotic and abiotic degradation processes that these compounds undergo in sewers, storage tanks, during engineered treatment and in the environment. Thus, the present study primarily investigated the degradation of the steroid progesterone (P4) in natural systems (rivers), with a focus on the identification and characterisation of transformation products. Initial work focussed on assessing the removal of selected compounds (Diclofenac, Fluoxetine, Propranolol and P4) from reed beds, with identification of transformation products in a field site being attempted. However, it was determined that concentrations of parent compounds and products would be too low to work with in the field, and a laboratory study was designed which focussed on P4. Focus on P4 was based on literature evidence of its rapid biodegradability relative to the other model compounds and its usage patterns globally. River water sampling for the laboratory-based degradation study was carried out at 1 km downstream of four south east England sewage works (Blackbirds, Chesham, High Wycombe and Maple Lodge) effluent discharge points. Suspected P4 transformation products were initially identified from predictions by the EAWAG Biocatalysis Biodegradation Database (EAWAG BBD) and from a literature review. At a later stage of the present work, a replacement model for EAWAG BBD (enviPath) which became available, was used to predict P4 degradation and results were compared.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley Et Al
    US 2014O144429A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley et al. (43) Pub. Date: May 29, 2014 (54) METHODS AND DEVICES FOR COMPOUND (60) Provisional application No. 61/887,045, filed on Oct. DELIVERY 4, 2013, provisional application No. 61/831,992, filed on Jun. 6, 2013, provisional application No. 61/794, (71) Applicant: E-NICOTINE TECHNOLOGY, INC., 601, filed on Mar. 15, 2013, provisional application Draper, UT (US) No. 61/730,738, filed on Nov. 28, 2012. (72) Inventors: Martin Wensley, Los Gatos, CA (US); Publication Classification Michael Hufford, Chapel Hill, NC (US); Jeffrey Williams, Draper, UT (51) Int. Cl. (US); Peter Lloyd, Walnut Creek, CA A6M II/04 (2006.01) (US) (52) U.S. Cl. CPC ................................... A6M II/04 (2013.O1 (73) Assignee: E-NICOTINE TECHNOLOGY, INC., ( ) Draper, UT (US) USPC ..................................................... 128/200.14 (21) Appl. No.: 14/168,338 (57) ABSTRACT 1-1. Provided herein are methods, devices, systems, and computer (22) Filed: Jan. 30, 2014 readable medium for delivering one or more compounds to a O O Subject. Also described herein are methods, devices, systems, Related U.S. Application Data and computer readable medium for transitioning a Smoker to (63) Continuation of application No. PCT/US 13/72426, an electronic nicotine delivery device and for Smoking or filed on Nov. 27, 2013. nicotine cessation. Patent Application Publication May 29, 2014 Sheet 1 of 26 US 2014/O144429 A1 FIG. 2A 204 -1 2O6 Patent Application Publication May 29, 2014 Sheet 2 of 26 US 2014/O144429 A1 Area liquid is vaporized Electrical Connection Agent O s 2.
    [Show full text]
  • WO 2014/085719 Al 5 June 2014 (05.06.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/085719 Al 5 June 2014 (05.06.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61M 15/00 (2006.01) A24F 47/00 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/US20 13/072426 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 27 November 2013 (27.1 1.2013) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 61/730,738 28 November 2012 (28. 11.2012) US 61/794,601 15 March 2013 (15.03.2013) US (84) Designated States (unless otherwise indicated, for every 61/83 1,992 6 June 2013 (06.06.2013) us kind of regional protection available): ARIPO (BW, GH, 61/887,045 4 October 201 3 (04.
    [Show full text]